Circulation: Heart Failure, Ahead of Print. Background:Empagliflozin reduces the risk of hospitalization for heart failure in patients with type 2
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreBackground: Treatment with sacubitril-valsartan reduces mortality and heart failure (HF) events in HF with reduced ejection fraction and may reduce
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Background:New heart failure therapies that safely augment cardiac contractility and output are needed. Previous
Read moreCirculation: Cardiovascular Quality and Outcomes, Ahead of Print. Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice
Read moreCirculation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Among Medicare value-based payment programs for acute myocardial infarction (AMI), the Hospital
Read moreKaren E. Joynt Maddox Karen E. Joynt Maddox, MD, MPH, Washington University School of Medicine, 660 S Euclid Ave, St.
Read more
